Articles Archives - Page 603 of 733

FridayMay 31, 2019 9:53 am

Endonovo Therapeutics Inc. (ENDV) to Distribute Non-Invasive, Wearable Therapeutic Devices to Nation’s Veteran Health Care Facilities

Endonovo’s flagship product, SofPulse, is an easy-to-place, non-invasive device delivering pulsed electromagnetic frequencies to enhance post-surgical recovery The company’s agreement with Veterans Healthcare Supply Solutions Inc. includes distribution of SofPulse to Veterans Administration facilities and Department of Defense health care facilities Treatment with SofPulse allows patients to better manage post-operative pain without the adverse side effects of narcotics and anti-inflammatory medications Endonovo holds patents and trademarks for several proprietary technologies and devices Endonovo Therapeutics Inc. (OTCQB: ENDV) is a commercial stage developer of non-invasive medical devices designed to deliver proprietary, patent protected Electroceutical Therapy for the treatment of inflammatory conditions,…

ThursdayMay 30, 2019 11:20 am

Nabis Holdings (CSE: NAB) (OTC: INNPF) (FRA: 71P) Participates in Inaugural Cannabis Forum, Purchases Facility in Washington

Nabis Holdings discussed the importance of cannabis legislative changes during an inaugural edition of a congressional cannabis forum in Washington, DC The company also announced the acquisition of a cannabis extraction and production facility in Washington state Through modernization and expansion, the company plans to ramp up the facility’s production capacity to 20,500 kilograms per year Jade Green, special advisor to Nabis Holdings (CSE: NAB) (OTC: INNPF) (FRA: 71P), participated in the KCSA Strategic Communications’ Inaugural Congressional Cannabis Day Forum that took place in Washington, DC on May 21, 2019. Green attended a panel discussing important legislative changes such as…

ThursdayMay 30, 2019 10:52 am

Geyser Brands Inc. (TSX.V: GYSR) Expands Production Facility, Hopes to Capitalize on CBD Wellness Markets

Geyser Brands recently commenced upgrades; it anticipates R&D and processing amendments The facility expansion is expected to improve the company’s focus on processing quality and consumer satisfaction Solace Management Group recently increased its production capacity and invested in new equipment for consumer health care and pet wellness production Geyser Brands Inc. (TSX.V: GYSR) is a leading Vancouver-based consumer health care company producing some of the world’s most popular cannabis brands and products. The company’s licensed producer (LP), Apothecary Botanicals, has received Health Canada license amendment approval to update its 7,000-square-foot facility located in Port Coquitlam, British Columbia. This expansion, anticipated…

ThursdayMay 30, 2019 10:25 am

Endonovo Therapeutics Inc. (ENDV) is “One to Watch”

Long-term agreement signed with Veterans Healthcare Supply Solutions Inc. to directly distribute SofPulse devices to Veterans Administration Facilities and Department of Defense Healthcare Facilities Partnership with SunMED Medical Solutions, one of the premier medical equipment distributors and claim experts in the U.S., expands Endonovo’s distribution capabilities and expands ability of providers, facilities and patients to seek medical insurance reimbursement Holds 27 patents and numerous trademarks for several proprietary technologies and devices Agreement signed with national recognized hospital for use of SofPulse devices for wound healing and pain management Nationwide network of independent sales representatives and distributors Endonovo Therapeutics Inc. (OTCQB:…

ThursdayMay 30, 2019 10:01 am

INmune Bio Inc. (NASDAQ: INMB) Developing Novel Immunotherapies Targeting Alzheimer’s Disease, Cancer

INmune Bio is a diversified, clinical stage immunology company developing novel therapies targeting distinct parts of a patient’s innate immune system to fight disease Drug candidates INKmune and INB03 may be used to treat cancer; XPro1595 targets neuroinflammation as a cause of Alzheimer’s disease The company was awarded a $1 million “Part the Cloud” grant from the Alzheimer’s Association to advance XPro1595 research INmune recently entered a common stock purchase agreement for up to $20 million with Lincoln Park Capital INmune Bio Inc. (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient’s innate immune system to…

WednesdayMay 29, 2019 11:30 am

South Africa Distribution Pact Expands Global Reach of Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)

The global hemp cannabidiol market is expected to top $22 billion worldwide by 2022, with CBD products comprising 25 percent of all cannabis sales Wildflower Brands is expanding the wellness reach of its cannabis products through a distribution pact with South African cannabis network provider Africann The company is also launching into Europe with a Polish network agreement through pharmaceutical distributor Two Towers Cannabis-based wellness brand champion Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) continues to expand the reach of its holistic plant product portfolio, inking an exclusive distribution agreement for the South African natural betterment market this month. The…

WednesdayMay 29, 2019 11:07 am

Genprex Inc. (NASDAQ: GNPX) Hires Top Pharmaceutical Branding Agency to Oversee Drug Naming Process for Lead Drug Candidate

Genprex, a clinical stage gene therapy company, will be utilizing the services of a leading pharmaceutical branding agency to oversee the naming process of its lead drug candidate, Oncoprex Addison Whitney has over 28 years of experience in the market, guiding pharmaceutical companies such as Merck, Celgene and Roche through the regulatory steps involved in the name approval process Oncoprex is an innovative immunogene therapy targeting non-small cell lung cancer Genprex Inc. (NASDAQ: GNPX), a clinical stage gene therapy company, recently reported that it has retained the services of leading pharmaceutical branding agency Addison Whitney to assist with the naming…

WednesdayMay 29, 2019 10:44 am

Beyond Meat Inc. (NASDAQ: BYND) to Release Financial Results for Q1 2019 in June

Beyond Meat’s financial results will be announced during a conference call scheduled for June 6 A live webcast will also be available via the company’s official website for investors interested in the financial information Beyond Meat’s portfolio of plant-based foods that replicate the taste and texture of meat has grown in popularity since the company’s launch in 2009, and its products are now available at more than 30,000 retail locations around the world Beyond Meat Inc. (NASDAQ: BYND), a leading provider of plant-based meat substitute products, recently announced that its financial results for the first quarter of 2019 will be…

WednesdayMay 29, 2019 10:09 am

INmune Bio Inc. (NASDAQ: INMB) is “One to Watch”

INmune Bio’s IPO closed February 1, 2019, with NASDAQ Capital Markets listing on February 4, 2019 Public clinical-stage immunology company with programs in oncology and neurodegenerative disease INmune Bio targets large markets with unsolved problems such as resistance to checkpoint inhibitor therapy, a fast-growing oncology market segment; MRD, the cause of cancer relapse; and neuroinflammation as a cause of Alzheimer’s disease Receiver of “Part the Cloud” $1 million grant awarded by Alzheimer’s Association Experienced leadership with extensive experience in the targeted fields of clinical research and drug development Intellectual property with multiple filings in process for INB03/XPro1595 and INKmune Insider…

TuesdayMay 28, 2019 12:31 pm

Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G) Seeks to Transform Cannabis Beverage and Edibles Market with Water-Soluble Tech

Sproutly is a licensed producer with exclusive rights to Infusion Biosciences’ groundbreaking Aqueous Phytorecovery Process (“APP”) technology for naturally water-soluble cannabinoids The Canadian cannabis beverage market is estimated to exceed $4 billion by 2022 SRUTF executives were tapped to present APP technology at key cannabis conferences Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF) (FRA: 38G) is rapidly gaining positive exposure in the cannabis space as the company presents its proprietary APP technological platform at numerous key cannabis conferences in the U.S. and Canada. Sproutly executives most recently shared details of the APP process at the Canaccord Genuity Third Annual Cannabis Conference…

Site Search

Company Search

Category: Articles